Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tanezumab in Osteoarthritis of the Knee
NCT00733902Phase 3Completed
- Sponsor
- Pfizer
- Start
- Sep 2008
- Primary completion
- Aug 2009
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of tanezumab in knee osteoarthritis (OA), sponsored by Pfizer. Started Sep 2008; status: completed.
02
Drugs
tanezumab
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT00733902.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00733902.